Source:http://linkedlifedata.com/resource/pubmed/id/20303781
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2010-5-7
|
pubmed:abstractText |
Primary biliary cirrhosis (PBC) is a TH1/Th17 biased autoimmune disease of the medium and small bile ducts. The role of the costimulatory TNFSF9 (4-1BBL) in PBC progress was investigated by comparing its cell surface expression in peripheral blood mononuclear cells (PBMC) by flow cytometry, its mRNA expression in PBMCs by QRT-PCR and its serum concentrations in PBC patients vs. healthy controls. The TNFSF9 expression levels were compared with Mayo risk scores, PBC stages, IL-18 serum levels, total bilirubin (TBIL), and gamma glutamyltransferase (gamma-GT). The PBC patients expressed significantly greater levels of membrane bound TNFSF9, mRNA on peripheral blood mononuclear cells (PBMC), and soluble TNFSF9 (P<0.05) than healthy controls. Stage III and IV PBC subjects showed significantly reduced TNFSF9 mRNA than stage I and II. The TBIL, gamma-GT, and IL-18 were greatly increased in PBC patients compared with healthy controls. Stage II, III, and IV patients exhibited significantly higher IL-18 levels than stage I subjects. TNFSF9 mRNA significantly correlated with serum TBIL, gamma-GT, and IL-18 (P<0.05, P<0.01, P<0.01). Thus, TNFSF9 mRNA levels in PBMC may be associated with PBC progression, provide new clues for monitoring its condition and pathogenesis.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/4-1BB Ligand,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-18,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/TNFSF9 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/gamma-Glutamyltransferase
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1096-0023
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright 2010 Elsevier Ltd. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
50
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
311-6
|
pubmed:meshHeading |
pubmed-meshheading:20303781-4-1BB Ligand,
pubmed-meshheading:20303781-Case-Control Studies,
pubmed-meshheading:20303781-Disease Progression,
pubmed-meshheading:20303781-Female,
pubmed-meshheading:20303781-Gene Expression Regulation,
pubmed-meshheading:20303781-Humans,
pubmed-meshheading:20303781-Interleukin-18,
pubmed-meshheading:20303781-Leukocytes, Mononuclear,
pubmed-meshheading:20303781-Liver Cirrhosis, Biliary,
pubmed-meshheading:20303781-Male,
pubmed-meshheading:20303781-Middle Aged,
pubmed-meshheading:20303781-RNA, Messenger,
pubmed-meshheading:20303781-Risk Factors,
pubmed-meshheading:20303781-Statistics, Nonparametric,
pubmed-meshheading:20303781-gamma-Glutamyltransferase
|
pubmed:year |
2010
|
pubmed:articleTitle |
TNFSF9 expression in primary biliary cirrhosis and its clinical significance.
|
pubmed:affiliation |
Department of Transfusion, Huashan Hospital, Fudan University, Shanghai 200040, China.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|